Structural analyses of choroid after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy

被引:59
|
作者
Izumi, Takahiko [1 ]
Koizumi, Hideki [1 ]
Maruko, Ichiro [1 ]
Takahashi, Yohei [1 ]
Sonoda, Shozo [2 ]
Sakamoto, Taiji [2 ]
Iida, Tomohiro [1 ]
机构
[1] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan
[2] Kagoshima Univ, Dept Ophthalmol, Kagoshima, Japan
关键词
OPTICAL COHERENCE TOMOGRAPHY; INDOCYANINE GREEN ANGIOGRAPHY; EYES; BINARIZATION; THICKNESS; IMAGES;
D O I
10.1136/bjophthalmol-2016-308921
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims To investigate the changes in the intrachoroidal structures after half-dose verteporfin photodynamic therapy (PDT) for central serous chorioretinopathy (CSC). Methods Swept-source optical coherence tomography cross-sectional images of 22 eyes of 22 patients with CSC were retrospectively analysed by a manual delineation technique and binarisation method. Results In the 22 eyes, the mean subfoveal choroidal thickness decreased from 412.9 +/- 112.9 mu m at baseline to 340.0 +/- 111.0 mu m at 3 months (p< 0.0001). The mean thickness of the large choroidal vessel layer decreased from 368.7 +/- 112.7 mu m at baseline to 292.2 +/- 118.0 mu m at 3 months (p< 0.0001), but the mean choriocapillarismedium choroidal vessel layer thickness did not change from 44.2 +/- 29.2 mu m at baseline to 47.8 +/- 25.7 mu m at 3 months (p= 0.85). Analyses of the binarised choroidal images showed that a 3 mm subfoveal choroidal area decreased from 1.141 +/- 0.290 mm(2) at baseline to 0.962 +/- 0.320 mm(2) at 3 months after PDT (p= 0.0001). The mean luminal areas decreased from 0.826 +/- 0.246 mm(2) at baseline to 0.665 +/- 0.234 mm(2) at 3 months (p= 0.0001), however, the mean stromal areas did not change from 0.315 +/- 0.066 mm(2) at baseline to 0.297 +/- 0.095 mm(2) at 3 months (p= 0.60). Conclusions Half-dose PDT reduces subfoveal choroidal thickness and alters the intrachoroidal structures in eyes with CSC.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 50 条
  • [21] Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy
    Ratanasukon, Mansing
    Thongthong, Koblarp
    Bhurayanontachai, Patama
    Jirarattanasopa, Pichai
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 87 - 92
  • [22] Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy
    Esen, Ebru
    Sizmaz, Selcuk
    Demircan, Nihal
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [23] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Atik, Alp
    Hu, Yijun
    Yu, Honghua
    Yang, Chun
    Cai, Bin
    Tao, Yijing
    Li, Dongli
    Chen, Yan
    Lu, Li
    Li, Guodong
    Yuan, Ling
    BMC OPHTHALMOLOGY, 2017, 17
  • [24] Choroidal hemodynamics in central serous chorioretinopathy after half-dose photodynamic therapy and the effects of smoking
    Horiguchi, Etsuyo
    Takeuchi, Jun
    Tomita, Ryo
    Asai, Keiko
    Nakano, Yuyako
    Ota, Hikaru
    Taki, Yosuke
    Ito, Yasuki
    Terasaki, Hiroko
    Nishiguchi, Koji M.
    Kataoka, Keiko
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [25] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Alp Atik
    Yijun Hu
    Honghua Yu
    Chun Yang
    Bin Cai
    Yijing Tao
    Dongli Li
    Yan Chen
    Li Lu
    Guodong Li
    Ling Yuan
    BMC Ophthalmology, 17
  • [26] Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
    Alkin, Zeynep
    Perente, Irfan
    Ozkaya, Abdullah
    Alp, Dilek
    Agca, Alper
    Aygit, Ebru Demet
    Korkmaz, Selcuk
    Yazici, Ahmet Taylan
    Demirok, Ahmet
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 685 - 690
  • [27] IMPROVEMENT IN MULTIFOCAL ELECTRORETINOGRAPHY AFTER HALF-DOSE VERTEPORFIN PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY A Randomized Placebo-Controlled Trial
    Wu, Zenith H. Y.
    Lai, Ricky Y. K.
    Yip, Yolanda W. Y.
    Chan, Wai Man
    Lam, Dennis S. C.
    Lai, Timothy Y. Y.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (07): : 1378 - 1386
  • [28] COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Cheng, Cheng-Kuo
    Chang, Chun-Kai
    Peng, Chi-Hsien
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (02): : 325 - 333
  • [29] Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Nicolo, Massimo
    Eandi, Chiara M.
    Alovisi, Camilla
    Grignolo, Federico M.
    Traverso, Carlo Enrico
    Musetti, Donatella
    Piccolino, Felice Cardillo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (05) : 1033 - 1037
  • [30] Half-dose versus half-fluence photodynamic therapy for chronic central serous chorioretinopathy
    Matoba, Ryo
    Shiode, Yusuke
    Kawata, Tetsuhiro
    Hosokawa, Mio
    Kimura, Shuhei
    Morizane, Yuki
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)